Ligand Pharmaceuticals Incorporated Insider Transactions
Ligand Pharmaceuticals Incorporated Insider Trades History
Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
---|---|---|---|---|---|---|---|
Espinoza Octavio
CFO |
Sell | 5,000 @ $115.03 | $575,149 | 18,879 | 03/04/2025 | 03/06/2025 | |
Espinoza Octavio
CFO |
Sell | 2,104 @ $116.37 | $244,850 | 20,647 | 12/23/2024 | 12/26/2024 | |
LAMATTINA JOHN L
Director |
Sell | 2,406 @ $123.65 | $297,502 | 29,515 | 11/27/2024 | 12/02/2024 | |
Korenberg Matthew E
President & COO |
Sell | 7,090 @ $101.61 | $720,379 | 50,978 | 09/23/2024 | 09/24/2024 | |
Reardon Andrew
CLO & Secretary |
Sell | 2,000 @ $99.60 | $199,201 | 22,534 | 09/23/2024 | 09/25/2024 | |
Korenberg Matthew E
President & COO |
Sell | 2,481 @ $100.05 | $248,228 | 58,068 | 09/23/2024 | 09/24/2024 | |
Korenberg Matthew E
President & COO |
Sell | 201 @ $102.05 | $20,513 | 50,777 | 09/23/2024 | 09/24/2024 | |
Espinoza Octavio
CFO |
Sell | 200 @ $103.98 | $20,796 | 25,685 | 09/20/2024 | 09/24/2024 | |
Korenberg Matthew E
President & COO |
Sell | 6,275 @ $104.10 | $653,238 | 50,777 | 09/20/2024 | 09/24/2024 | |
Espinoza Octavio
CFO |
Sell | 275 @ $103.86 | $28,562 | 25,410 | 09/20/2024 | 09/24/2024 | |
Espinoza Octavio
CFO |
Sell | 800 @ $103.95 | $83,160 | 24,610 | 09/20/2024 | 09/24/2024 | |
Reardon Andrew
CLO & Secretary |
Sell | 1,500 @ $106.39 | $159,591 | 22,534 | 08/28/2024 | 08/30/2024 | |
Korenberg Matthew E
President & COO |
Sell | 6,177 @ $105.02 | $648,684 | 54,722 | 08/26/2024 | 08/26/2024 | |
Korenberg Matthew E
President & COO |
Sell | 5,212 @ $106.32 | $554,147 | 49,510 | 08/26/2024 | 08/26/2024 | |
Korenberg Matthew E
President & COO |
Sell | 2,037 @ $104.09 | $212,040 | 65,174 | 08/23/2024 | 08/26/2024 | |
Korenberg Matthew E
President & COO |
Sell | 4,275 @ $105.13 | $449,439 | 60,899 | 08/23/2024 | 08/26/2024 | |
Korenberg Matthew E
President & COO |
Sell | 1,157 @ $105.54 | $122,110 | 67,211 | 08/22/2024 | 08/26/2024 | |
Korenberg Matthew E
President & COO |
Sell | 18,245 @ $98.50 | $1.80 M | 68,368 | 08/09/2024 | 08/13/2024 | |
Davis Todd C
CEO |
Buy | 2,500 @ $97.39 | $243,481 | 123,010 | 08/08/2024 | 08/09/2024 | |
Espinoza Octavio
CFO |
Sell | 5,022 @ $86.67 | $435,233 | 23,513 | 05/17/2024 | 05/17/2024 |
Ligand Pharmaceuticals Incorporated FAQ's
The list of insiders at Ligand Pharmaceuticals Incorporated includes Gray Nancy Ryan, Espinoza Octavio, Davis Todd C, Korenberg Matthew E, Reardon Andrew, LAMATTINA JOHN L.
Insiders have sold a total of 79,398 Ligand Pharmaceuticals Incorporated shares in the last 12 months for a total of 8.06 M sold.
The following insiders have sold Ligand Pharmaceuticals Incorporated shares in the last 12 months: Gray Nancy Ryan ($77,713), Espinoza Octavio ($1.90 M), Korenberg Matthew E ($5.43 M), Reardon Andrew ($358,792), LAMATTINA JOHN L ($297,502),
Insiders have purchased a total of 2,500 Ligand Pharmaceuticals Incorporated shares in the last 12 months for a total of 243,481.
The following insiders have purchased Ligand Pharmaceuticals Incorporated shares in the last 12 months: Davis Todd C ($243,481),